
Viking Therapeutics: Playing Second Fiddle To Madrigal (NASDAQ:VKTX)
mi-viri/iStock via Getty Images Viking Therapeutics (NASDAQ:VKTX) was once going almost head to head with Madrigal Pharmaceuticals (MDGL) in treating liver diseases like biopsy-confirmed NASH and the milder NAFLD. However, the company has fallen behind, […]